Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Gastrointest Endosc

Retrieve available abstracts of 92 articles:
HTML format



Single Articles


    June 2022
  1. CHAN MW, Pouw RE
    Risk-stratification models for Barrett's esophagus: Will we get to the perfect classifier?
    Gastrointest Endosc. 2022;95:1123-1125.
    PubMed    


  2. THOTA PN, Nasibli J, Kumar P, Sanaka MR, et al
    Prediction of neoplastic progression in Barrett's esophagus using nanoscale nuclear architecture mapping: a pilot study.
    Gastrointest Endosc. 2022;95:1239-1246.
    PubMed     Abstract available


  3. NGUYEN TH, Thrift AP, Ketwaroo GA, Du XL, et al
    External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans.
    Gastrointest Endosc. 2022;95:1113-1122.
    PubMed     Abstract available


  4. DEMEESTER S, Smith C, Severson P, Loveitt A, et al
    Multicenter randomized controlled trial comparing forceps biopsy sampling with wide-area transepithelial sampling brush for detecting intestinal metaplasia and dysplasia during routine upper endoscopy.
    Gastrointest Endosc. 2022;95:1101-1110.
    PubMed     Abstract available


    April 2022
  5. YANG D, King W, Aihara H, Karasik MS, et al
    Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia.
    Gastrointest Endosc. 2022;95:626-633.
    PubMed     Abstract available


    March 2022
  6. CODIPILLY DC, Iyer PG
    What's next for wide-area transepithelial sampling in Barrett's esophagus management?
    Gastrointest Endosc. 2022;95:419-421.
    PubMed    


  7. AGARWAL S, Alshelleh M, Scott J, Dhaliwal L, et al
    Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study.
    Gastrointest Endosc. 2022;95:422-431.
    PubMed     Abstract available


  8. SHAHEEN NJ, Smith MS, Odze RD
    Progression of Barrett's esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis.
    Gastrointest Endosc. 2022;95:410-418.
    PubMed     Abstract available


    February 2022
  9. XU JQ, Zhang ZC, Chen WF, Xu MD, et al
    Repeated endoscopic submucosal dissection (ESD) as salvage treatment for local recurrence of esophageal squamous cell carcinoma after initial ESD.
    Gastrointest Endosc. 2022 Feb 28. pii: S0016-5107(22)00182.
    PubMed     Abstract available


  10. JOSEPH A, Draganov P, Maluf-Filho F, Aihara H, et al
    Outcomes for ESD of Pathologically Staged T1b Esophageal Cancer: A Multi-Center Study.
    Gastrointest Endosc. 2022 Feb 22. pii: S0016-5107(22)00123.
    PubMed     Abstract available


  11. HONING J, di Pietro M
    Surveillance for Barrett's esophagus: let's get the basics right.
    Gastrointest Endosc. 2022;95:246-248.
    PubMed    


  12. PARASA S, Wallace MB, Srinivasan S, Sundaram S, et al
    Educational intervention to improve quality of care in Barrett's esophagus: the AQUIRE randomized controlled trial.
    Gastrointest Endosc. 2022;95:239-245.
    PubMed     Abstract available


  13. GUO Q, Fan X, Zhu S, Zhao X, et al
    Comparing N-acetylcysteine with sodium thiosulfate for relieving symptoms caused by Lugol's iodine chromoendoscopy: a randomized, double-blind trial.
    Gastrointest Endosc. 2022;95:249-257.
    PubMed     Abstract available


    January 2022
  14. CODIPILLY DC, Krishna Chandar A, Wang KK, Katzka DA, et al
    Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis.
    Gastrointest Endosc. 2022;95:51-59.
    PubMed     Abstract available


  15. ADLER DG
    Esophageal papillomatosis presenting with complete esophageal obstruction and high positron emission tomography avidity.
    Gastrointest Endosc. 2022;95:187-188.
    PubMed    


  16. FARHA N, Hrabe J, Sleiman J, Beard J, et al
    Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome.
    Gastrointest Endosc. 2022;95:105-114.
    PubMed     Abstract available


    December 2021
  17. TANAKA I, Hirasawa D, Matsuda T
    Extremely small but invasive esophageal cancer: endoscopists should not miss it.
    Gastrointest Endosc. 2021 Dec 1. pii: S0016-5107(21)01847.
    PubMed    


    November 2021
  18. SATO D, Kadota T, Inaba A, Nishihara K, et al
    Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasion.
    Gastrointest Endosc. 2021 Nov 10. pii: S0016-5107(21)01781.
    PubMed     Abstract available


  19. FALK GW
    Low-grade dysplasia in Barrett's esophagus: More than meets the eye?
    Gastrointest Endosc. 2021;94:909-911.
    PubMed    


  20. TSOI EH, Mahindra P, Cameron G, Williams R, et al
    Barrett's esophagus with low-grade dysplasia: high rate of upstaging at Barrett's esophagus referral units suggests progression rates may be overestimated.
    Gastrointest Endosc. 2021;94:902-908.
    PubMed     Abstract available


    October 2021
  21. OVERWATER A, van Munster SN, Offerhaus GJA, Seldenrijk CA, et al
    Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy.
    Gastrointest Endosc. 2021;94:832-842.
    PubMed     Abstract available


    September 2021
  22. IWAMURO M, Fujii N, Tanabe S, Okada H, et al
    Desquamative esophagitis followed by esophageal cancer in a stem cell transplant recipient.
    Gastrointest Endosc. 2021 Sep 20. pii: S0016-5107(21)01650.
    PubMed    


  23. FREI NF, Bergman JJGHM, Pouw RE
    Screening for Barrett's esophagus: Ready for prime time or still hard to swallow?
    Gastrointest Endosc. 2021;94:506-508.
    PubMed    


  24. IYER PG, Taylor WR, Slettedahl SW, Lansing RL, et al
    Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study.
    Gastrointest Endosc. 2021;94:498-505.
    PubMed     Abstract available


    August 2021
  25. MONTGOMERY EA, Haidry R
    Treating esophageal squamous cell carcinoma with ablation: the fear of what lies beneath.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01495.
    PubMed    


  26. XIA R, Li H, Shi J, Liu W, et al
    Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01563.
    PubMed     Abstract available


  27. KAMBOJ AK, Leggett CL
    Barrett's esophagus indefinite for dysplasia carries a definite risk of neoplasia.
    Gastrointest Endosc. 2021;94:271-272.
    PubMed    


  28. DUPREE A, Ehlken H, Rosch T, Luken M, et al
    Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically.
    Gastrointest Endosc. 2021;94:282-290.
    PubMed     Abstract available


  29. EVERSON MA, Garcia-Peraza-Herrera L, Wang HP, Lee CT, et al
    A clinically interpretable convolutional neural network for the real-time prediction of early squamous cell cancer of the esophagus: comparing diagnostic performance with a panel of expert European and Asian endoscopists.
    Gastrointest Endosc. 2021;94:273-281.
    PubMed     Abstract available


  30. PHILLIPS R, Januszewicz W, Pilonis ND, O'Donovan M, et al
    The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study.
    Gastrointest Endosc. 2021;94:263-270.
    PubMed     Abstract available


    July 2021
  31. YANG LS, Holt BA, Williams R, Norris R, et al
    Endoscopic features of buried Barrett's mucosa.
    Gastrointest Endosc. 2021;94:14-21.
    PubMed     Abstract available


    June 2021
  32. BARTEL MJ, Mousa OY, Brahmbhatt B, Coffman DL, et al
    Impact of topical budesonide on prevention of esophageal stricture after mucosal resection.
    Gastrointest Endosc. 2021;93:1276-1282.
    PubMed     Abstract available


  33. SOLFISBURG QS, Sami SS, Gabre J, Soroush A, et al
    Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus.
    Gastrointest Endosc. 2021;93:1250-1257.
    PubMed     Abstract available


  34. ZHANG M, Zhu C, Wang Y, Kong Z, et al
    Differential diagnosis for esophageal protruded lesions using a deep convolution neural network in endoscopic images.
    Gastrointest Endosc. 2021;93:1261-1272.
    PubMed     Abstract available


    May 2021
  35. MWACHIRO MM, Dawsey SM
    Larger esophageal Lugol's unstained lesions need more follow-up: size as an important predictor for risk of premalignant lesions.
    Gastrointest Endosc. 2021;93:1074-1076.
    PubMed    


  36. DE GROOF J, Antonelli G, Dinis-Ribeiro MJ, Bergman JJ, et al
    Meta-analyses of machine learning in endoscopy: stacking apples and oranges.
    Gastrointest Endosc. 2021;93:1016-1018.
    PubMed    


  37. LIU M, Zhou R, Guo C, Xu R, et al
    Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.
    Gastrointest Endosc. 2021;93:1065-1073.
    PubMed     Abstract available


    April 2021
  38. BABA ER, Uedo N, Rodrigues AL, da Costa Martins B, et al
    "KERATIN PEARLS IN MAGNIFYING ENDOSCOPY OF SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA".
    Gastrointest Endosc. 2021 Apr 22. pii: S0016-5107(21)01313.
    PubMed    


  39. HAIDRY R
    Endoluminal resective therapy for residual esophageal neoplasia after definitive chemoradiotherapy: Who are we helping-the patient or the endoscopist?
    Gastrointest Endosc. 2021;93:899-901.
    PubMed    


  40. SWEI E, Wagh MS
    Endoscopic submucosal dissection in the pharynx: Let's start at the very beginning!
    Gastrointest Endosc. 2021;93:828-830.
    PubMed    


  41. SAPP AR, Wander P, Ali U, Gong Y, et al
    The tongue: an unusual site for esophageal adenocarcinoma metastasis diagnosed with EUS-guided FNA.
    Gastrointest Endosc. 2021;93:977-978.
    PubMed    


  42. KAHN A, Priyan H, Dierkhising RA, Johnson ML, et al
    Outcomes of radiofrequency ablation by manual versus self-sizing circumferential balloon catheters for the treatment of dysplastic Barrett's esophagus: a multicenter comparative cohort study.
    Gastrointest Endosc. 2021;93:880-887.
    PubMed     Abstract available


  43. STRUYVENBERG MR, de Groof AJ, Fonolla R, van der Sommen F, et al
    Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett's neoplasia.
    Gastrointest Endosc. 2021;93:871-879.
    PubMed     Abstract available


  44. HANADA Y, Wang KK
    Safety and feasibility of same-day discharge after esophageal endoscopic submucosal dissection.
    Gastrointest Endosc. 2021;93:853-860.
    PubMed     Abstract available


  45. IIZUKA T, Kikuchi D, Suzuki Y, Tanaka M, et al
    Clinical relevance of endoscopic treatment for superficial pharyngeal cancer: feasibility of techniques corresponding to each location and long-term outcomes.
    Gastrointest Endosc. 2021;93:818-827.
    PubMed     Abstract available


    March 2021
  46. KAUL V, Diehl D, Enslin S, Infantolino A, et al
    Safety and efficacy of a novel powered endoscopic debridement tissue resection device for management of difficult colon and foregut lesions: first multicenter U.S. experience.
    Gastrointest Endosc. 2021;93:640-646.
    PubMed     Abstract available


    February 2021
  47. DESAI M, Hamade N, Sharma P
    Screening for Barrett's esophagus: challenges in identifying the population at risk.
    Gastrointest Endosc. 2021;93:420-421.
    PubMed    


  48. CHEN Z, Ng H, Liu Y, Guo C, et al
    Endoscopic submucosal dissection of early squamous cell carcinoma of the soft palate.
    Gastrointest Endosc. 2021;93:517-518.
    PubMed    


    January 2021
  49. SUBRAMANIAN SK, Bhakta D, Thosani N
    Hepatocellular carcinoma masquerading as nodular Barrett's esophagus.
    Gastrointest Endosc. 2021 Jan 22. pii: S0016-5107(21)00038.
    PubMed    


  50. MOTOMURA D, Chung W, Bechara R
    Endoscopic therapy for T1b esophageal cancer.
    Gastrointest Endosc. 2021;93:282-283.
    PubMed    


  51. MWACHIRO MM, Dawsey SM
    The use of questionnaire-based risk-stratification tools in screening for esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2021;93:119-121.
    PubMed    


  52. MOLENA D, DeMeester SR
    Response.
    Gastrointest Endosc. 2021;93:284-285.
    PubMed    


  53. OTAKI F, Iyer PG
    Response.
    Gastrointest Endosc. 2021;93:283-284.
    PubMed    


  54. STRUYVENBERG MR, de Groof AJ, van der Putten J, van der Sommen F, et al
    A computer-assisted algorithm for narrow-band imaging-based tissue characterization in Barrett's esophagus.
    Gastrointest Endosc. 2021;93:89-98.
    PubMed     Abstract available


    December 2020
  55. BANG CS, Lee JJ, Baik GH
    Computer-aided diagnosis of esophageal cancer and neoplasms in endoscopic images: a systematic review and meta-analysis of diagnostic test accuracy.
    Gastrointest Endosc. 2020 Dec 5. pii: S0016-5107(20)35023.
    PubMed     Abstract available


  56. JACOBS C, Draganov PV, Yang D
    Endoscopic submucosal dissection for esophageal neoplasia in the West: Are we there yet?
    Gastrointest Endosc. 2020;92:1275-1276.
    PubMed    


  57. SAKAGUCHI Y, Tsuji Y, Shinozaki T, Ohki D, et al
    Steroid injection and polyglycolic acid shielding to prevent stricture after esophageal endoscopic submucosal dissection: a retrospective comparative analysis (with video).
    Gastrointest Endosc. 2020;92:1176-1186.
    PubMed     Abstract available


    November 2020
  58. ISSA D, Patel M, Shah T
    Esophagectomy versus endoscopic resection for T1b esophageal adenocarcinoma: Depth matters!
    Gastrointest Endosc. 2020;92:1147-1148.
    PubMed    


  59. ETEMADI A, Dawsey SM, Abnet CC, Mwachiro MM, et al
    Predicting the risk of esophageal high-grade lesions in opportunistic screening.
    Gastrointest Endosc. 2020;92:1136-1137.
    PubMed    


    September 2020
  60. KRISHNAMOORTHI R
    Endoscopic therapy or surveillance for Barrett's esophagus with low-grade dysplasia: time to involve patients in shared decision making.
    Gastrointest Endosc. 2020;92:575-577.
    PubMed    


  61. VAN MUNSTER SN, Bergman JJGHM, Pouw RE
    Successful endoscopic treatment of Barrett's dysplasia is not just about the destination; it is about the journey.
    Gastrointest Endosc. 2020;92:551-553.
    PubMed    


  62. POUW RE, Klaver E, Phoa KN, van Vilsteren FG, et al
    Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial.
    Gastrointest Endosc. 2020;92:569-574.
    PubMed     Abstract available


  63. LIPMAN G, Markar S, Gupta A, Haidry RJ, et al
    Learning curves and the influence of procedural volume for the treatment of dysplastic Barrett's esophagus.
    Gastrointest Endosc. 2020;92:543-550.
    PubMed     Abstract available


  64. JIN D, Wang J, Zhan Q, Huang K, et al
    The safety and efficacy of 2% vitamin C solution spray for relief of mucosal irritation caused by Lugol chromoendoscopy: a multicenter, randomized, double-blind, parallel trial.
    Gastrointest Endosc. 2020;92:554-564.
    PubMed     Abstract available


    August 2020
  65. AL-KAABI A, Schoon EJ, Deprez PH, Seewald S, et al
    Salvage endoscopic resection after definitive chemoradiotherapy for esophageal cancer: a Western experience.
    Gastrointest Endosc. 2020 Aug 4. pii: S0016-5107(20)34657.
    PubMed     Abstract available


  66. TAN S, Peng Y, Tang X
    Endoscopic surveillance of esophageal cancer before the treatment of achalasia.
    Gastrointest Endosc. 2020;92:457-458.
    PubMed    


    July 2020
  67. MOLENA D, DeMeester SR
    When less is just less: endoscopic therapy for submucosal T1b esophageal cancer.
    Gastrointest Endosc. 2020;92:40-43.
    PubMed    


  68. NIEUWENHUIS EA, Bergman JJ, Pouw RE
    What to do with our T1b esophageal adenocarcinoma patients?
    Gastrointest Endosc. 2020;92:226.
    PubMed    


  69. OTAKI F, Iyer PG
    Response.
    Gastrointest Endosc. 2020;92:226-227.
    PubMed    


  70. CHAN MQ, Balasubramanian G, Modi RM, Papachristou GI, et al
    Changing epidemiology of esophageal stent placement for dysphagia: a decade of trends and the impact of benign indications.
    Gastrointest Endosc. 2020;92:56-64.
    PubMed     Abstract available


  71. PITA I, Gigliano D, Afonso LP, Libanio D, et al
    Esophageal pseudoperforation during band mucosectomy of Barrett's esophagus: not all that glitters is gold (with video).
    Gastrointest Endosc. 2020;92:212-214.
    PubMed    


  72. OTAKI F, Ma GK, Krigel A, Dierkhising RA, et al
    Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study.
    Gastrointest Endosc. 2020;92:31-39.
    PubMed     Abstract available


    June 2020
  73. FUKUDA H, Ishihara R, Kato Y, Matsunaga T, et al
    Comparison of performances of artificial intelligence versus expert endoscopists for real-time assisted diagnosis of esophageal squamous cell carcinoma (with video).
    Gastrointest Endosc. 2020 Jun 4. pii: S0016-5107(20)34378.
    PubMed     Abstract available


  74. CHEN W, Li H, Zheng R, Ren J, et al
    An initial screening strategy based on epidemiological information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.
    Gastrointest Endosc. 2020 Jun 3. pii: S0016-5107(20)34402.
    PubMed     Abstract available


  75. DU C, Chai N, Linghu E, Tang X, et al
    Spraying vitamin C solution for relief of mucosal irritation caused by Lugol chromoendoscopy.
    Gastrointest Endosc. 2020;91:1409-1410.
    PubMed    


  76. PERBTANI Y, Qumseya BJ
    A prediction model for detection of esophageal squamous cell cancer: A new beginning or more of the same?
    Gastrointest Endosc. 2020;91:1261-1263.
    PubMed    


  77. HASHIMOTO R, Requa J, Dao T, Ninh A, et al
    Artificial intelligence using convolutional neural networks for real-time detection of early esophageal neoplasia in Barrett's esophagus (with video).
    Gastrointest Endosc. 2020;91:1264-1271.
    PubMed     Abstract available


  78. DE GROOF AJ, Struyvenberg MR, Fockens KN, van der Putten J, et al
    Deep learning algorithm detection of Barrett's neoplasia with high accuracy during live endoscopic procedures: a pilot study (with video).
    Gastrointest Endosc. 2020;91:1242-1250.
    PubMed     Abstract available


  79. LIU Z, Guo C, He Y, Chen Y, et al
    A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China.
    Gastrointest Endosc. 2020;91:1253-1260.
    PubMed     Abstract available


    May 2020
  80. DE GROOF AJ, Fockens KN, Struyvenberg MR, Pouw RE, et al
    Blue-light imaging and linked-color imaging improve visualization of Barrett's neoplasia by nonexpert endoscopists.
    Gastrointest Endosc. 2020;91:1050-1057.
    PubMed     Abstract available


    April 2020
  81. MCCARTY JC, Parker RK, Vidri RJ, Robinson KA, et al
    A retrospective cohort study of endoscopic therapy and esophagectomy for stage 1 esophageal cancer: less is more.
    Gastrointest Endosc. 2020 Apr 7. pii: S0016-5107(20)30034.
    PubMed     Abstract available


  82. ALSAYID M, Melson J
    Will magnet-assisted capsule endoscopy become a viable screening tool for Barrett's esophagus and esophageal varices?
    Gastrointest Endosc. 2020;91:782-784.
    PubMed    


  83. PECH O
    Lugol staining for early esophageal neoplasia: less is sometimes more.
    Gastrointest Endosc. 2020;91:771-772.
    PubMed    


  84. GENERE JR, Priyan H, Sawas T, Hanada Y, et al
    Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia.
    Gastrointest Endosc. 2020;91:797-805.
    PubMed     Abstract available


  85. LIU D, Yu XH, Zheng QF, Liu BR, et al
    A giant lumen-occluding hemangioma at the cervical esophagus resected by endoscopic submucosal dissection.
    Gastrointest Endosc. 2020;91:944-945.
    PubMed    


  86. GOTODA T, Kanzaki H, Okamoto Y, Obayashi Y, et al
    Tolerability and efficacy of the concentration of iodine solution during esophageal chromoendoscopy: a double-blind randomized controlled trial.
    Gastrointest Endosc. 2020;91:763-770.
    PubMed     Abstract available


    February 2020
  87. SUBRAMANIAM S, Kandiah K, Schoon E, Aepli P, et al
    Development and validation of the international Blue Light Imaging for Barrett's Neoplasia Classification.
    Gastrointest Endosc. 2020;91:310-320.
    PubMed     Abstract available


  88. OHMORI M, Ishihara R, Aoyama K, Nakagawa K, et al
    Endoscopic detection and differentiation of esophageal lesions using a deep neural network.
    Gastrointest Endosc. 2020;91:301-309.
    PubMed     Abstract available


  89. FRANCOIS S, Waldbillig C, Lasser L, Ngassa M, et al
    Giant fibrovascular polyp of the esophagus.
    Gastrointest Endosc. 2020;91:442-443.
    PubMed    


  90. KURIBAYASHI S, Matsumura N, Sohda M, Kuwano H, et al
    Risk of perforation during endoscopic resection of esophageal lesions in patients with systemic sclerosis.
    Gastrointest Endosc. 2020;91:441-442.
    PubMed    


  91. GUPTA N, Kumar T, Rao SA
    EUS-guided FNA from suspected bony metastasis in the vertebral body.
    Gastrointest Endosc. 2020;91:445-446.
    PubMed    


    January 2020
  92. KRISHNAMOORTHI R, Mohan BP, Jayaraj M, Wang KK, et al
    Risk of progression in Barrett's esophagus indefinite for dysplasia: a systematic review and meta-analysis.
    Gastrointest Endosc. 2020;91:3-10.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: